Stock VTGN VISTAGEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Vistagen Therapeutics, Inc.

Equities

VTGN

US92840H4002

Market Closed - Nasdaq
Other stock markets
 01:30:03 01/06/2024 am IST 		5-day change 1st Jan Change
3.865 USD -0.64% Intraday chart for Vistagen Therapeutics, Inc. -5.27% -24.81%
23/05 Vistagen Therapeutics, Inc. to Present At the 2024 American Society of Clinical Psychopharmacology Conference CI
25/04 Vistagen Announces Positive Results from Phase 2A Pilot Study of Ph15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VISTAGEN THERAPEUTICS, INC. Stock Vistagen Therapeutics, Inc.
 10Cr - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 12TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
BIONTECH SE Stock BioNTech SE
 2.43TCr -
ARGENX SE Stock argenx SE
 2.2TCr -
GENMAB A/S Stock Genmab A/S
 1.82TCr
  1. Stock Market
  2. Equities
  3. VTGN Stock
  4. Charts Vistagen Therapeutics, Inc.
  5. Sector Chart